Kiniksa raises 2026 ARCALYST sales guidance, confirms KPL-387 data timingOct 27Regulatory decisionAlvotechFirst Tracks Biotherapeutics, Inc.Updated
FDA accepts BLA for Alvotech's AVT80, a subcutaneous Entyvio biosimilar candidateAug 31PartnershipAlvotechvedolizumab